Immunohistochemically Detected Tumor Cells in the Sentinel Lymph Nodes of Patients with Breast Carcinoma: Biologic Metastasis or Procedural Artifact?

Cancer

Volumn 100, Issue 5, 2004, Pages 929-934

  Moore, Katrina H ^a   Thaler, Howard T ^a   Tan, Lee K ^a   Borgen, Patrick I ^a   Cody III, Hiram S ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Breast carcinoma; Epithelial displacement; Immunohistochemistry; Micrometastases; Sentinel lymph node; Sentinel lymph node biopsy

Indexed keywords

CYTOKERATIN; EOSIN; HEMATOXYLIN;

ARTICLE; ASPIRATION BIOPSY; BREAST CARCINOMA; CANCER DIAGNOSIS; CANCER INVASION; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY; TUMOR CELL; TUMOR LOCALIZATION; TUMOR VOLUME;

ADULT; AGED; ANALYSIS OF VARIANCE; BIOPSY, NEEDLE; BREAST NEOPLASMS; CARCINOMA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LOGISTIC MODELS; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROBABILITY; PROGNOSIS; PROSPECTIVE STUDIES; REGISTRIES; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY;

EID: 1242336809     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.20035     Document Type: Article

References (31)

1. Krag DN, Weaver DL, Alex JC, et al. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol. 1993;2:335-340.
2. Giuliano AE, Kirgan DM, Guenther JM, et al. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg. 1994;220:391-401.
3. Turner RR, Ollila DW, Krasne DL, et al. Histologic validation of the sentinel lymph node hypothesis for breast carcinoma. Ann Surg. 1997;226:271-278.
4. Giuliano AE, Dale PS, Turner RR, et al. Improved staging of breast cancer with sentinel lymphadenectomy. Ann Surg. 1995;3:394-401.
5. Liberman L. Pathologic analysis of sentinel lymph nodes in breast carcinoma. Cancer. 2000;88:971-977.
6. Weiser MR, Montgomery LL, Tan LK, et al. Lymphovascular invasion enhances the prediction of non-sentinel node metastases in breast cancer patients with positive sentinel nodes. Ann Surg Oncol. 2001;8:145-149.
7. Turner RR, Chu KU, Qi K, et al. Pathologic features associated with nonsentinel lymph node metastases in patients with metastatic breast carcinoma in a sentinel lymph node. Cancer. 2000;89:574-581.
8. Rosser RJ. A point of view: trauma is the cause of occult micrometastatic breast cancer in sentinel axillary lymph nodes. Breast J. 2000;6:209-212.
9. Carter BA, Jensen RA, Simpson JF, et al. Benign transport of breast epithelium into axillary lymph nodes after biopsy. Am J Clin Pathol. 2000;113:259-265.
10. Sauven P, Bishop H, Patnick J, et al. The National Health Service Breast Screening Programme and British Association of Surgical Oncology audit of quality assurance in breast screening 1996-2001. Br J Surg. 2003;90:82-87.
11. Cody HS, Borgen PI. State-of-the-art approaches to sentinel node biopsy for breast cancer: study design, patient selection, technique, and quality control at Memorial Sloan-Kettering Cancer Center. Surg Oncol. 1999;8:85-91.
12. Klauber-DeMore N, Tan LK, Liberman L, et al. Sentinel lymph node biopsy: is it indicated in patients with high-risk ductal carcinoma-in-situ and ductal carcinoma-in-situ with microinvasion? Ann Surg Oncol. 2000;7:636-642.
13. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347:1233-1241.
14. Fisher B, Jeong JH, Anderson S, et al. Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med. 2002;347:567-575.
15. Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;347:1227-1232.
16. Fisher B. Laboratory and clinical research in breast cancer: a personal adventure: The David A. Karnofsky memorial lecture. Cancer Res. 1980;40:3863-3874.
17. Dowlatshahi K, Fan M, Snider HC, et al. Lymph node micrometastases from breast carcinoma: reviewing the dilemma. Cancer. 1997;80:1188-1197.
18. International (Ludwig) Breast Cancer Study Group. Prognostic importance of occult axillary lymph node micrometastases from breast cancers. Lancet. 1990;335:1565-1568.
19. Greene FL, Page DL, Fleming ID, et al. AJCC cancer staging manual, 6th edition. New York: Springer-Verlag, 2002.
20. Cote RJ, Peterson HF, Chaiwun B, et al. Role of immunohistochemical detection of lymph-node metastases in management of breast cancer. Lancet. 1999;354:896-900.
21. Tan LK, Giri D, Panageas K, et al. Occult micrometastases in axillary lymph nodes of breast cancer patients are significant: a retrospective study with long-term follow-up [abstract]. Proc Am Soc Clin Oncol. 2002;21:37a.
22. Hermanek P, Hutter RVP, Sobin LH, et al. Classification of isolated tumor cells and micrometastasis. Cancer. 1999;86:2668-2673.
23. Giuliano AE, Haigh PI, Brennan M, et al. Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer. J Clin Oncol. 2000;18:2553-2559.
24. Krag DN, Harlow S, Weaver D, et al. Radiolabeled sentinel node biopsy: collaborative trial with the National Cancer Institute. World J Surg. 2001;25:823-828.
25. Youngson BJ, Liberman L, Rosen PP. Displacement of carcinomatous epithelium in surgical breast specimens following stereotaxic core biopsy. Am J Clin Pathol. 1995;103:598-602.
26. Youngson BJ, Cranor M, Rosen PP. Epithelial displacement in surgical breast specimens following needling procedures. Am J Surg Pathol. 1994;18:896-903.
27. King TA, Ganaraj A, Fey J, et al. Cytokeratin-positive cells in sentinel lymph nodes in breast cancer are not random events: experience in patients undergoing prophylactic mastectomy [abstract]. Proc Am Soc Clin Oncol. 2003;22:14a.
28. Diel IJ, Kaufmann M, Costa SD, et al. Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status. J Natl Cancer Inst. 1996;88:1652-1664.
29. Braun S, Pantel K, Muller P, et al. Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer. N Engl J Med. 2000;342:525-533.
30. van't Veer LJ, Dai H, van de Vijver MJ, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature. 2002;415:530-536.
31. van de Vijver MJ, He YD, van't Veer LJ, et al. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med. 2002;347:1999-2009.